TABLE 1.
Antimicrobial effects of EbEO in association to antibiotics.
| S. aureus | Source | Resistance profile | MIC (μg/mL) |
| ATCC 29213 | Standard strain | – | 128 |
| UFPEDA 02 (= ATCC 6538) | Standard strain | – | 256 |
| UFPEDA 659 | Catheter tip | NAL/OXA | 128 |
| UFPEDA 671 | Bone fragment | AMI/AMP/CIP/CLI/CLO/GEN/NAL/OXA/TET/TRI | 512 |
| UFPEDA 679 | Surgical wound secretion | AMI/CLI/AMP/CFL/CFZ/NAL/OXA/VAN | 128 |
| UFPEDA 683 | Purulent exudate | AMI/AMP/CIP/CFL/CFO/CFZ/CLI/CLO/CPM/CRX/CTX/GEN/NAL/OXA/TRI/VAN | 8 |
| UFPEDA 691 | Catheter tip | CIP/CLO/NAL | 128 |
| UFPEDA 705 | Surgical wound | AMP/CFL/CFO/CPM/CRX/NAL/NIT/OXA/GEN | 256 |
| UFPEDA 726 | Nasal secretion | AMP/CIP/CLO/GEN/OXA/TRI | 128 |
| UFPEDA 731 | Surgical wound secretion | AMP/CFL/CFO/CLI/CLO/CRX/CIP/GEN/NAL/OXA/TRI | 512 |
| UFPEDA 802 | Nasal secretion | AMI/AMP/OXA/CFL/CFO/CFZ/CIP/CLI/CLO/CPM/CRX/CTX/GEN/NAL/TET/TRI | 512 |
AMI: amikacin; AMP: ampicillin; CFL: cephalothin; CFZ: cefazolin; CPM: cefepime; CFO: cefoxitin; CIP: ciprofloxacin; CLI: clindamycin; CLO: chloramphenicol; CRX: cefuroxime; CTX: cefotaxime; GEN: gentamicina; IMI: imipenem; MER: meropenem; NAL: nalidixic acid; NIT: nitrofurantoin; OXA: oxacillin; TET: tetracycline; TRI: trimethoprim; VAN: vancomycin. MICs were obtained using the microdilution method as described.